1. Home
  2. UNTY vs ADCT Comparison

UNTY vs ADCT Comparison

Compare UNTY & ADCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Unity Bancorp Inc.

UNTY

Unity Bancorp Inc.

HOLD

Current Price

$53.96

Market Cap

523.6M

Sector

Finance

ML Signal

HOLD

Logo ADC Therapeutics SA

ADCT

ADC Therapeutics SA

HOLD

Current Price

$3.65

Market Cap

439.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UNTY
ADCT
Founded
1991
2011
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
523.6M
439.8M
IPO Year
1997
2020

Fundamental Metrics

Financial Performance
Metric
UNTY
ADCT
Price
$53.96
$3.65
Analyst Decision
Buy
Strong Buy
Analyst Count
2
6
Target Price
$65.00
$7.60
AVG Volume (30 Days)
46.8K
635.1K
Earning Date
01-13-2026
11-10-2025
Dividend Yield
1.11%
N/A
EPS Growth
39.66
N/A
EPS
5.67
N/A
Revenue
$127,871,000.00
$75,209,000.00
Revenue This Year
$11.57
$12.48
Revenue Next Year
$8.52
$5.12
P/E Ratio
$9.52
N/A
Revenue Growth
23.99
6.35
52 Week Low
$36.65
$1.05
52 Week High
$57.24
$4.80

Technical Indicators

Market Signals
Indicator
UNTY
ADCT
Relative Strength Index (RSI) 54.73 49.60
Support Level $51.31 $3.25
Resistance Level $53.11 $3.81
Average True Range (ATR) 1.71 0.22
MACD -0.09 0.02
Stochastic Oscillator 53.05 63.28

Price Performance

Historical Comparison
UNTY
ADCT

About UNTY Unity Bancorp Inc.

Unity Bancorp Inc is a bank holding company that serves as a holding company for Unity Bank. It conducts a traditional and community-oriented commercial banking business and offers services, including personal and business checking accounts, time deposits, money market accounts, regular savings accounts, and others. The company structures its specific services and charges in a manner designed to attract the business of small and medium-sized businesses and professional communities, as well as individuals residing, working, and shopping in its service area. The company engages in a wide range of lending activities and offers commercial, Small Business Administration, consumer, mortgage, home equity, and personal loans.

About ADCT ADC Therapeutics SA

ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's FDA-approved and marketed product, ZYNLONTA (loncastuximab tesirine), is a CD19-directed antibody and alkylating agent conjugate indicated for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. In addition, it also has various other product candidates in its pipeline, such as ADCT-602, Claudin-6, PSMA, NaPi2b, and ASCT2. Geographically, the company generates maximum revenue from the United States, followed by Europe, the Middle East and Africa (EMEA).

Share on Social Networks: